Eight months after it was approved for sale in India, anti-diabetic drug Mounjaro is India’s highest-selling drug, even beating the antibiotic Augmentin, and it’s not because diabetes has spiked ...
While 2025 has been crucial for establishing the clinical credibility of GLP-1 agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro), 2026 will mark the 'patent cliff' that will democratise ...
Eye patients who are allergic to penicillin can now have an alternative antibiotic injected into the eye during cataract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback